Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential effects of epidermal growth factor receptor inhibitors in a single patient with neuropathic pain.

BMJ case reports - 26 Mar 2021

Cameron Marte Grønlie, Kersten Christian

Abstract excerpt

Neuropathic pain (NP) represents an unmet medical need, where analgesic responses to different epidermal growth factor receptor inhibitors (EGFR-Is) have been described. The human EGFR family of receptors consists of four members (human epidermal growth factor receptor, HER 1-4), signalling via different homodimer and heterodimer combinations. A 52-year-old man was treated with the EGFR-I cetuximab in a trial of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Afatinib
Share to ErbB Receptors
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neuralgia

Share to Protein Kinase Inhibitors

Share to Quinazolines

Source

Open in PubMed Open full text

Identifiers

PMID: 33771774
DOI: 10.1136/bcr-2020-239385
PMCID: PMC8006768

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential effects of epidermal growth factor receptor inhibitors in a single patient with neuropathic pain.PMID 33771774Read ↗

Cancer pain: current practice and emerging targetsSemantic proximity Read ↗

Cancer Pain is Not One Size Fits All: Evolving from Tradition to PrecisionSemantic proximity Read ↗

Perioperative EGFR-Targeted Therapy in Resectable EGFR-Mutated NSCLC: A Narrative Review from Drug Design to Pain-Informed MRD-Guided Care.Semantic proximity Read ↗

Advances in the Pathophysiology and Management of Cancer Pain: A Scoping ReviewSemantic proximity Read ↗

Evolving Paradigms in Cancer Pain Management: From Opioid-Centric Care to Multimodal and Personalized StrategiesSemantic proximity Read ↗

Neurobiology of Cancer Pain: A Narrative ReviewSemantic proximity Read ↗

The dichotomous role of epiregulin in painSemantic proximity Read ↗

Epiregulin and EGFR interactions are involved in pain processing.Semantic proximity Read ↗

Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients.Semantic proximity Read ↗

Individualized pharmacological treatment of neuropathic pain.Semantic proximity Read ↗

Lidocaine transdermal patch reduced the pain intensity in neuropathic cancer patients with opioid treatmentSemantic proximity Read ↗

Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatabilitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.